“Dushu Lake Prize”Selection of China Pharmaceutical Innovation Brand“Dushu Lake Prize”Selection of China Pharmaceutical Innovation Brand

010-58156160-822

CN
Introduction

To facilitate the internationalization of Chinese innovative brands by promoting and implementing the national Innovation Driven Development Strategy, enhancing the core competitiveness of innovative technology and advancing the process of strengthening the nation by technology and pharmaceutical development, China Pharmaceutical Innovation and Research Development Association (PhIRDA) and Suzhou Industrial Park have reached a consensus on co-hosting the “Dushu Lake Prize” Selection Activities of China Pharmaceutical Innovation Brand (herein after referred to as the Selection Activities) in 2018. Both sides will join hands to make the Selection Activities a fair, just, and open session.

The Selection Activities adopts the mechanism of expert recommendation. Any applications from enterprises shall not be taken into consideration. The selection will follow the peer review system of international innovation standards and scientific awards to set the awards for the most innovative drugs, figures (Chinese scientists) and financial institutions.

Experts List
Awards List
Awards List

Anlotinib Hydrochloride Capsules Chia Tai Tianqing Pharma

Awards List

Ankon Magnetically Controlled Capsule Endoscopy
Ankon Technologies (Wuhan) Co., Ltd.

Awards List

Vacancy

Awards List

Enterovirus Type 71 Inactivated Vaccines (human diploid cell)  Institute of Medical Biology Chinese Academy of Medical Sciences

Awards List

Jiang Lixin Fuwai Hospital of Chinese Academy of Medical Sciences
Huo Yong Peking University First Hospital

Awards List

Wu Beili Shanghai Institute of Materia Medica of Chinese Academy of Sciences
Yang Dajun Ascentage Pharma

Awards List

Chen Lieping Yale School of Medicine

Awards List

Chen Kaixian Shanghai Institute of Materia Medica of Chinese Academy of Sciences

Awards List

Lilly Asia Ventures
YuanMing Capital
GTJA Investment Group
Dimensions Capital
Efung Investment

Video of 2016 Selection
Photos of 2016 Selection
Contact Us

Office of Selection Activities

Zhang Lin
Tel:010-58156160-821
Mobile:157 1133 7989
E-mail:zhangl@phirda.com
Zhang Zhao
Tel:010-58156160-822
Mobile:188 1307 5508
E-mail:zhangz@phirda.com
Downloads